MRI fusion biopsy of the prostate is a sophisticated procedure for the diagnosis of prostate cancer. The team of specialists at alta uro was among the pioneers in the use of this procedure.
MRI fusion biopsy combines state-of-the-art imaging using MRI with the safe and precise procedure of perineal prostate biopsy.
Tissue is removed specifically from areas of the prostate suspected of containing tumors. In this way, our patients benefit from state-of-the-art technology. MRI fusion biopsy, which is now recommended in important guidelines, has already been performed regularly at alta uro since 2016.
Our experts on the topic MRI fusion biopsy of the prostate gland
The advantage of MRI fusion biopsy prostate is its accuracy and precision.
When is a prostate biopsy necessary?
If prostate cancer is suspected, a tissue sample must be taken from the prostate. The suspected diagnosis of prostate cancer is made by an increase in PSA (prostate specific antigen) in the blood or a conspicuous digito rectal palpation of the prostate. Regular biopsies are also performed as part of the so-called active surveillance for less aggressive prostate cancer.
What is the difference between a conventional biopsy and an MRI fusion biopsy of the prostate?
In conventional biopsy, about 12 to 18 samples are usually taken under local anesthesia through the rectum under ultrasound guidance. Since suspicious areas in the prostate cannot be reliably visualized by ultrasound, the sampling is performed according to a scheme, but not in a targeted manner. In contrast, MRI fusion biopsy is based on high-resolution magnetic resonance imaging (MRI) of the prostate. Thus, areas in the prostate that are suspicious for tumors can be detected with a very high degree of certainty. During the MRI fusion biopsy, samples are then taken specifically from the suspicious areas. At alta uro, the MRI fusion biopsy is supplemented by systematic biopsies of the prostate.
What is the procedure for MRI fusion biopsy of the prostate?
At alta uro, the MRI fusion biopsy of the prostate is performed under a short anesthesia at the Merian Iselin Klinik in Basel. Access is via the perineum. This allows precise access to all areas of the prostate. The risk of infection is minimal compared to biopsy via the rectum. The MRI images are fused with the ultrasound images of the prostate in real time using state-of-the-art computer technology. Subsequently, targeted tissue sampling is performed and the biopsies are sent for analysis. The result is available after 2 to 3 working days.
Member of the Swiss Society of Urology Member of the Quality Register of the Swiss Society of Urology Certified cooperation partner of the German Cancer Society Certified medical advice center of the German Continence Society
